A brave new world? Measuring trends in percutaneous coronary intervention for stable angina after COURAGE.
نویسنده
چکیده
More than 4 years have elapsed since the publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial,1 which led to rampant speculation regarding its potential impact on clinical practice. As memories of the heated rhetoric that punctuated that debate fade, we are now in a position to look back with calmer heads and use observational data to see whether COURAGE was indeed associated with changes in the use of percutaneous coronary intervention (PCI). Given the importance of the issue ( 600 000 patients underwent PCI in 2007),2 assessing the impact of COURAGE is an important test of the ability of these observational data resources to measure not only the presence of evidence-associated changes in practice, but also the pace and magnitude of those changes.
منابع مشابه
Trends in PCI volume after negative results from the COURAGE trial.
OBJECTIVE To describe trends in the use of percutaneous coronary intervention (PCI) following the COURAGE trial, which found that medical therapy is as effective as PCI for patients with stable angina. DATA SOURCES We used the National Hospital Discharge Survey; inpatient and outpatient discharge data from Florida, Maryland, and New Jersey; and the English Hospital Episode Statistics database...
متن کاملRecent changes in practice of elective percutaneous coronary intervention for stable angina.
BACKGROUND The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial was designed to compare optimal medical therapy alone versus optimal medical therapy and percutaneous coronary intervention (PCI) for treatment of patients with stable coronary artery disease and showed equal efficacy for optimal medical therapy with or without PCI. The impact of results ...
متن کاملRevisiting the role of percutaneous coronary interventions in stable angina: The landscape after the COURAGE trial.
متن کامل
Tibolone and the promise of ideal hormone-replacement therapy.
n engl j med 359;7 www.nejm.org august 14, 2008 753 Future PCI/stent use among stable angina patients could 2. depend on COURAGE: managed care first report. (Accessed July 25, 2008, at http://www.mccfirstreport.com/show_story. php?newsid=1172.) Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on 3. quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677-87. Spe...
متن کاملThe truth and consequences of the COURAGE trial.
Percutaneous coronary intervention (PCI) has played an integral role in the therapeutic management strategies for patients who present with either acute coronary syndromes or stable angina pectoris. The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial enrolled patients with chronic stable angina and at least 1 significant (> or =70%) angiographic coro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation. Cardiovascular quality and outcomes
دوره 4 3 شماره
صفحات -
تاریخ انتشار 2011